Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.58 |
| ▸ | NPC1 | O15118 | 1/20 | 0.58 |
| ▸ | GAA | P10253 | 1/20 | 0.58 |
| ▸ | RAB9A | P51151 | 1/20 | 0.58 |
| ▸ | MGLL | Q99685 | 2/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1891640 | 0.89 | MGLL (0.66) | MGLL | |
| SCHEMBL13055389 | 0.88 | TAAR1 (0.60) | TAAR1NPC1GAARAB9A | |
| SCHEMBL1456951 | 0.88 | MGLL (0.70) | MGLL | |
| SCHEMBL28570445 | 0.86 | MGLL (0.73) | MGLL | |
| SCHEMBL21891896 | 0.86 | MGLL (0.73) | MGLL | |
| SCHEMBL28333275 | 0.86 | MGLL (0.73) | MGLL | |
| SCHEMBL28335638 | 0.86 | MGLL (0.73) | MGLL | |
| SCHEMBL22472046 | 0.86 | MGLL (0.73) | MGLL | |
| SCHEMBL6757093 | 0.86 | MGLL (0.73) | MGLL | |
| SCHEMBL27554564 | 0.86 | MGLL (0.73) | MGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113024418-B | Method for synthesizing alicyclic carbamate by using isopropanol as hydrogen source | 河北工业大学 | 2023-01-24 | — | — | CN | claimed |
| CN-113926403-A | Preparation device and method of diphenylmethane dicarbamic acid ester | 中国科学院过程工程研究所 | 2022-01-14 | — | — | CN | claimed |
| CN-112898184-A | Method for continuously synthesizing alicyclic carbamate | 河北工业大学 | 2021-06-04 | — | — | CN | claimed |
| CN-100491368-C | Dioxane-2-alkyl carbamate derivatives | SANOFI AVENTIS (FR) | 2009-05-27 | — | — | CN | claimed |
| CN-1777595-A | Dioxane-2-alkylcarbamate derivatives, their preparation and their therapeutic use | SANOFI AVENTIS (FR) | 2006-05-24 | — | — | CN | claimed |
| CN-1759095-A | N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives | ELAN PHARM INC (US) | 2006-04-12 | — | — | CN | claimed |
| JP-3167104-A | — | — | None | — | — | JP | disclosed |
| CN-119019380-A | Benzimidazole-6-sulfonylurea compound and medical application thereof | 南京羚诺生物医药技术研究院有限公司 | 2024-11-26 | — | — | CN | disclosed |
| EP-4446310-A1 | METHOD FOR PRODUCING BLOCKED ISOCYANATE COMPOUND AND METHOD FOR PRODUCING ISOCYANATE COMPOUND | Asahi Kasei Kabushiki Kaisha (JP) | 2024-10-16 | — | — | EP | disclosed |
| WO-2023106377-A1 | METHOD FOR PRODUCING BLOCKED ISOCYANATE COMPOUND AND METHOD FOR PRODUCING ISOCYANATE COMPOUND | 旭化成株式会社 | 2023-06-15 | — | — | WO | disclosed |
| CN-112020493-B | Method for producing urethane and method for producing isocyanate | 旭化成株式会社 | 2023-04-21 | — | — | CN | disclosed |
| CN-113024418-B | Method for synthesizing alicyclic carbamate by using isopropanol as hydrogen source | 河北工业大学 | 2023-01-24 | — | — | CN | disclosed |
| WO-2022075347-A1 | METHOD FOR PRODUCING OCTAHYDROTHIENOQUINOLINE COMPOUND, AND PRODUCTION INTERMEDIATE OF SAME | キッセイ薬品工業株式会社 | 2022-04-14 | — | — | WO | disclosed |
| EP-1522540-A1 | AZAARENE DERIVATIVES | Eisai Co., Ltd. (JP) | 2005-04-13 | — | — | EP | disclosed |
| EP-1506962-A2 | Nitrogen-containing aromatic heterocycles | Eisai Co. Ltd. (JP) | 2005-02-16 | — | — | EP | disclosed |
| EP-1415987-A1 | NITROGENOUS AROMATIC RING COMPOUNDS | Eisai Co., Ltd. (JP) | 2004-05-06 | — | — | EP | disclosed |
| US-20040053908-A1 | Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2004-03-18 | — | — | US | disclosed |
| CN-1478078-A | Nitrogen-containing aromatic ring derivatives | ������������ʽ���� | 2004-02-25 | — | — | CN | disclosed |
| JP-H03167104-A | FLOWERING PROMOTER OF ASPARAGUS | MITSUBISHI KASEI CORP | 1991-07-19 | — | — | JP | disclosed |
| US-3938986-A | ISOPROPYL N-PHENYLCARBAMATE OR ISOPROPYL N-(3-CHLOROPHENYL)CARBAMATE AND 4-CHLOROPHENYL N-METHYLCARBAMATE | PPG INDUSTRIES, INC. (US) | 1976-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040053908-A1 | Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective | VEGFA, UACA, UTS2R | TAAR1 2021/4885NPC1 1179/4885GAA 1408/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.